Korczynska Justyna, Stelmanska Ewa, Nogalska Anna, Szolkiewicz Marek, Goyke Elzbieta, Swierczynski Julian, Rutkowski Boleslaw
Department of Biochemistry, Medical University of Gdansk, Poland.
Metabolism. 2004 Aug;53(8):1060-5. doi: 10.1016/j.metabol.2004.02.015.
Chronic renal failure (CRF) frequently results in hypertriglyceridemia and elevated plasma concentration of very-low-density lipoprotein (VLDL). These abnormalities are thought to be primarily due to depressed lipoprotein lipase and hepatic lipase activities, as well as impaired clearance of plasma lipoproteins. Some results suggest that not only lipoproteins catabolism but also their overproduction might contribute to hypertriglyceridemia in CRF. Because sterol regulatory element binding protein (SREBP) plays an important role in the regulation of lipid homeostasis, increased level of this transcription factor might be involved in modulating lipid metabolism in CRF. The purpose of the present study is to determine whether there is an altered regulation of the SREBP-1 in CRF rats and whether the altered regulation of SREBP-1 is associated with the upregulation of lipogenic enzymes genes expression in CRF rats. In the white adipose tissue (WAT) of CRF rats, marked increases in the microsomal (precursor) and nuclear (mature) forms of SREBP-1 have been found. The increase in SREBP-1 was associated with an increased level of lipogenic enzymes (acetyl-coenzyme A [CoA] carboxylase [ACC], adenosine triphosphate-citrate lyase [ACL], fatty acid synthase [FAS], glucose 6-phosphate dehydrogenase [G6PDH], 6-phosphogluconate dehydrogenase [6PGDH], and malic enzyme [ME]) genes expression. In turn, this was associated with an increased rate of fatty acids synthesis in WAT and a significant increase in plasma triacylglycerol (TAG) and VLDL concentration. Our study indicates that WAT SREBP-1 expression is increased in CRF rats and that SREBP-1 may play an important role in the increased fatty acid synthesis. These results reveal another facet of disturbed lipid metabolism in CRF.
慢性肾衰竭(CRF)常导致高甘油三酯血症以及极低密度脂蛋白(VLDL)血浆浓度升高。这些异常被认为主要是由于脂蛋白脂肪酶和肝脂肪酶活性降低,以及血浆脂蛋白清除受损所致。一些结果表明,不仅脂蛋白分解代谢,而且其过度产生可能导致CRF中的高甘油三酯血症。由于固醇调节元件结合蛋白(SREBP)在脂质稳态调节中起重要作用,该转录因子水平的升高可能参与调节CRF中的脂质代谢。本研究的目的是确定CRF大鼠中SREBP-1的调节是否发生改变,以及SREBP-1调节的改变是否与CRF大鼠中脂肪生成酶基因表达的上调有关。在CRF大鼠的白色脂肪组织(WAT)中,已发现SREBP-1的微粒体(前体)和核(成熟)形式显著增加。SREBP-1的增加与脂肪生成酶(乙酰辅酶A [CoA]羧化酶[ACC]、三磷酸腺苷 - 柠檬酸裂解酶[ACL]、脂肪酸合酶[FAS]、葡萄糖6 - 磷酸脱氢酶[G6PDH]、6 - 磷酸葡萄糖酸脱氢酶[6PGDH]和苹果酸酶[ME])基因表达水平的增加有关。反过来,这又与WAT中脂肪酸合成速率的增加以及血浆三酰甘油(TAG)和VLDL浓度的显著增加有关。我们的研究表明,CRF大鼠中WAT的SREBP-1表达增加,并且SREBP-1可能在脂肪酸合成增加中起重要作用。这些结果揭示了CRF中脂质代谢紊乱的另一个方面。